title: Evaluation of hypothalamic-pituitary-adrenal axis (HPA) suppression by low-dose (0.5 microg) and standard-dose (250 microg) adrenocorticotropic hormone (ACTH) tests in asthmatic children treated with inhaled corticosteroid (JPEM 2006; 19: 1015-1023).
authors.forename: K N
authors.initials: KN
authors.lastname: Priftis
authors.forename: A
authors.initials: A
authors.lastname: Papadimitriou
authors.forename: M B
authors.initials: MB
authors.lastname: Anthracopoulos
authors.forename: A
authors.initials: A
authors.lastname: Fretzayas
authors.forename: P
authors.initials: P
authors.lastname: Nicolaidou
mesh_terms: D000280:Administration, Inhalation; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D019819:Budesonide / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004305:Dose-Response Relationship, Drug; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects* / Q000503:physiopathology; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000503:physiopathology
chemical_list: D000305:Adrenal Cortex Hormones; D019819:Budesonide; D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone